MAP 2.94% 17.5¢ microba life sciences limited

Ann: Q4 FY23 Quarterly Investor Presentation, page-9

  1. 292 Posts.
    lightbulb Created with Sketch. 105
    i think the writing is on the wall partnership's with some majors. Meta xplore getting great growth and feedback and Sonic taking Australia wide then internationally. Meta panel looking like some exciting news coming up this quarter and Sonic taking the first distribution rights. This is cutting edge and the speculation is going to show up with some more announcements. If Microba gets consistent overseas growth and phase 1 is successful this could really well
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.